RESERPINE AND HYDROFLUMETHIAZIDE Drug Patent Profile
When do Reserpine And Hydroflumethiazide patents expire, and what generic alternatives are available?
Reserpine And Hydroflumethiazide is a drug marketed by Ivax Pharms and Par Pharm and is included in two NDAs.
The generic ingredient in RESERPINE AND HYDROFLUMETHIAZIDE is hydroflumethiazide; reserpine. There is one drug master file entry for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for RESERPINE AND HYDROFLUMETHIAZIDE?
- What are the global sales for RESERPINE AND HYDROFLUMETHIAZIDE?
- What is Average Wholesale Price for RESERPINE AND HYDROFLUMETHIAZIDE?
Summary for RESERPINE AND HYDROFLUMETHIAZIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 34 |
| Patent Applications: | 122 |
| DailyMed Link: | RESERPINE AND HYDROFLUMETHIAZIDE at DailyMed |
US Patents and Regulatory Information for RESERPINE AND HYDROFLUMETHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Pharms | RESERPINE AND HYDROFLUMETHIAZIDE | hydroflumethiazide; reserpine | TABLET;ORAL | 088932-001 | Jan 11, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Par Pharm | RESERPINE AND HYDROFLUMETHIAZIDE | hydroflumethiazide; reserpine | TABLET;ORAL | 088907-001 | Sep 20, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
